Enable Accessibility Enable Accessibility

About T-CiRA


Collaborative research aiming to develop innovative treatments over a 10-year period

T-CiRA is a joint research program by the Center for iPS Cell Research and Application (CiRA), Kyoto University and Takeda Pharmaceutical Company Limited. Over a 10-year period and under the direction of CiRA, this joint program will conduct research to develop clinical applications of iPS cells. We aim to develop innovative drugs and cell treatments in such areas as heart failure, diabetes mellitus, neuro-psychiatric disorders, cancer and intractable muscle diseases in order to fulfill the needs of patients promptly.

web_icon_vision.png

Our vision:
the long-term goal that we strive to reach.

A world with the prospect of
Better Health through the infinite Power of Science


web_icon_purpose.png

Our purpose:
why we exist as an organization.


Transform medicine with the unlimited potential of
iPS cells


web_icon_mission.png

Our mission:
how we accomplish our purpose.


Discover the seeds of treatment options
and nurture them for clinical application


web_icon_identity.png

Our identity:
who we are.


I
NNOVATORS
Opening up new possibilities in healthcare without fear of failure

P
IONEERS
Always keeping up with patients’ needs using the wisdom of science

S
CIENTISTS
Conducting next-generation research for drug discovery within an industry-academia collaboration


T-CiRA_logo.png

3logos.png

10year.png

200billion.png

10project.png

100man.png

Research area_E.png



button_pdf_E.png